Lambert Skoog

13.7k total citations · 2 hit papers
270 papers, 10.3k citations indexed

About

Lambert Skoog is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Lambert Skoog has authored 270 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Oncology, 94 papers in Cancer Research and 82 papers in Genetics. Recurrent topics in Lambert Skoog's work include Breast Cancer Treatment Studies (73 papers), Estrogen and related hormone effects (66 papers) and HER2/EGFR in Cancer Research (38 papers). Lambert Skoog is often cited by papers focused on Breast Cancer Treatment Studies (73 papers), Estrogen and related hormone effects (66 papers) and HER2/EGFR in Cancer Research (38 papers). Lambert Skoog collaborates with scholars based in Sweden, United States and Brazil. Lambert Skoog's co-authors include Bo Nordenskjöld, Olle Stål, Edneia Tani, Lars Erik Rutqvist, Tommy� Fornander, Bo von Schoultz, Gunnar Söderqvist, Edneia Tani, Jonas Bergh and Björn Cedermark and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Lambert Skoog

264 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS

1989 685 citations Tommy� Fornander, Björn Cedermark et al. profile →
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

2005 613 citations Yudi Pawitan, Judith Bjöhle et al. Breast Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lambert Skoog Sweden	50	4.3k	3.8k	3.5k	2.9k	1.7k	270	10.3k
Gert Auer Sweden	58	3.8k 0.9×	4.9k 1.3×	3.9k 1.1×	1.6k 0.6×	2.2k 1.3×	373	11.7k
J. Dirk Iglehart United States	57	4.8k 1.1×	5.5k 1.5×	3.2k 0.9×	1.9k 0.7×	1.4k 0.8×	138	10.8k
Elizabeth A. Musgrove Australia	60	6.6k 1.6×	7.4k 2.0×	3.2k 0.9×	3.0k 1.0×	1.3k 0.7×	144	13.6k
Shinzaburo Noguchi Japan	64	6.1k 1.4×	5.1k 1.4×	5.2k 1.5×	2.5k 0.9×	2.1k 1.2×	389	13.7k
Gary C. Chamness United States	48	5.7k 1.3×	4.9k 1.3×	3.4k 1.0×	3.6k 1.3×	832 0.5×	95	11.3k
Irene L. Andrulis Canada	53	4.3k 1.0×	5.4k 1.4×	2.9k 0.8×	2.5k 0.9×	1.6k 0.9×	243	10.7k
Rosette Lidereau France	70	6.3k 1.5×	9.5k 2.5×	5.0k 1.4×	3.3k 1.1×	2.0k 1.2×	263	16.1k
Generoso Bevilacqua Italy	49	3.8k 0.9×	5.5k 1.4×	1.9k 0.5×	1.1k 0.4×	1.9k 1.1×	283	10.3k
Bo Nordenskjöld Sweden	49	4.5k 1.1×	2.8k 0.7×	3.1k 0.9×	2.1k 0.7×	1.2k 0.7×	211	8.2k
Laura J. van’t Veer Netherlands	54	5.4k 1.3×	5.2k 1.4×	4.6k 1.3×	2.2k 0.8×	1.5k 0.9×	123	11.7k

Countries citing papers authored by Lambert Skoog

Since Specialization

Citations

This map shows the geographic impact of Lambert Skoog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lambert Skoog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lambert Skoog more than expected).

Fields of papers citing papers by Lambert Skoog

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lambert Skoog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lambert Skoog. The network helps show where Lambert Skoog may publish in the future.

Co-authorship network of co-authors of Lambert Skoog

This figure shows the co-authorship network connecting the top 25 collaborators of Lambert Skoog. A scholar is included among the top collaborators of Lambert Skoog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lambert Skoog. Lambert Skoog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foukakis, Theodoros, John Lövrot, Alexios Matikas, et al.. (2018). Immune gene expression and response to chemotherapy in advanced breast cancer. British Journal of Cancer. 118(4). 480–488. 37 indexed citations

Tani, Edneia, et al.. (2017). A Review of the Use of Fine-Needle Aspiration Biopsy of Mammary Tumors for Diagnosis and Research. Acta Cytologica. 61(4-5). 305–315. 4 indexed citations

Kimbung, Siker, Ida Johansson, Anna Danielsson, et al.. (2015). Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis–Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer. Clinical Cancer Research. 22(1). 146–157. 36 indexed citations

Peng, Zheng, Lambert Skoog, Henrik Hellborg, et al.. (2014). An expression signature at diagnosis to estimate prostate cancer patients’ overall survival. Prostate Cancer and Prostatic Diseases. 17(1). 81–90. 33 indexed citations

Weiner, Maria, et al.. (2013). Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer. Annals of Oncology. 24(8). 1994–1999. 18 indexed citations

Tani, Edneia, et al.. (2011). HER2status in operable breast cancers from Vietnamese women: Analysis by immunohistochemistry (IHC) and automated silver enhancedin situhybridization (SISH). Acta Oncologica. 50(3). 360–366. 7 indexed citations

Bostner, Josefine, Lambert Skoog, Tommy� Fornander, Bo Nordenskjöld, & Olle Stål. (2010). Estrogen Receptor-α Phosphorylation at Serine 305, Nuclear p21-Activated Kinase 1 Expression, and Response to Tamoxifen in Postmenopausal Breast Cancer. Clinical Cancer Research. 16(5). 1624–1633. 48 indexed citations

Bergqvist, Jenny, John Öhd, Johanna Smeds, et al.. (2007). Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome. Annals of Oncology. 18(5). 845–850. 31 indexed citations

Bergqvist, Jenny, Göran Elmberger, John Öhd, et al.. (2006). Activated ERK1/2 and phosphorylated oestrogen receptor α are associated with improved breast cancer survival in women treated with tamoxifen. European Journal of Cancer. 42(8). 1104–1112. 43 indexed citations

10.

Stål, Olle, Gizeh Pérez‐Tenorio, Birgit Olsson, et al.. (2003). Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Research. 5(2). R37–44. 140 indexed citations

11.

Martinsson, Tommy, Edneia Tani, Sture Falkmer, et al.. (1999). The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children. Cancer. 87(2). 60–68. 22 indexed citations

12.

Isaksson, Eva, J. Mark Cline, Lambert Skoog, et al.. (1999). p53 expression in breast and endometrium during estrogen and tamoxifen treatment of surgically postmenopausal cynomolgus macaques. Breast Cancer Research and Treatment. 53(1). 61–67. 7 indexed citations

13.

Zelada-Hedman, M, et al.. (1997). Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families. British Journal of Cancer. 75(8). 1201–1204. 15 indexed citations

14.

Stål, Olle, Marie Stenmark Askmalm, Sten Wingren, et al.. (1995). P53 Expression and the Result of Adjuvant Therapy of Breast Cancer. Acta Oncologica. 34(6). 767–770. 32 indexed citations

15.

Stål, Olle, Lambert Skoog, Lars Erik Rutqvist, et al.. (1994). S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer. British Journal of Cancer. 70(6). 1258–1262. 49 indexed citations

16.

Zelada-Hedman, M, Lennart Iselius, Peter Gunvén, et al.. (1994). Genetic rearrangements in sporadic and familial gastric carcinomas detected with microsatellite markers.. PubMed. 20(6). 667–73. 7 indexed citations

17.

Berglund, Gunilla, et al.. (1993). Lack of correlation between anxiety parameters and oestrogen receptor status in early breast cancer. European Journal of Cancer. 29(9). 1325–1326. 7 indexed citations

18.

Schimmelpenning, H., et al.. (1992). Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ.. PubMed. 97(5 Suppl 1). S48–52. 36 indexed citations

19.

Skoog, Lambert, et al.. (1986). Detection of TdT in AML blasts by immunological and biochemical techniques.. PubMed. 6(2). 281–2.

20.

Rudling, Mats, Elisabeth Ståhle, Curt Peterson, & Lambert Skoog. (1986). Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients.. BMJ. 292(6520). 580–582. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact